Quest Diagnostics Incorporated (DGX) Comparison with companies in other sectors?

Quest Diagnostics Incorporated has a share price of 111.64M. You can analyze Quest Diagnostics Incorporated (DGX) competitors across different market sectors through stock heatmaps.

What are DGX's NET and operating margins?

Quest Diagnostics Incorporated (DGX) operating margin is around 0.14, and net profit margin is approximately 0.09 as of the latest reports.

In what way does DGX's earnings per share (EPS) trend reflect its financial momentum?

Quest Diagnostics Incorporated (DGX) EPS is 8.35 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Quest Diagnostics Incorporated is 20.19, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Quest Diagnostics Incorporated?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Quest Diagnostics Incorporated like P/E which is 19.92, P/B which is 2.62, and PEG which is 3.47. Compare them with sector averages to evaluate if the stock is priced fairly.

Quest Diagnostics Incorporated

DGX•NYSE

Healthcare

Medical - Diagnostics & Research

$168.55

$-3.35(-1.95%)

Fundamental Analysis of Quest Diagnostics Incorporated (DGX)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$8.35

P/E Ratio

20.19

ROE

0.14%

Net Margin

0.09%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$18.82B

Shares OutstandingTotal number of shares issued

$111.64M

Book Value/ShareNet worth per share

$65.59

Revenue/ShareAnnual revenue per share

$93.95

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$8.35

Net MarginNet income as percentage of revenue

9.02%

Operating MarginOperating income as percentage of revenue

13.89%

ROEReturn on shareholders' equity

13.68%

ROAReturn on total assets

5.94%

ROCEReturn on capital employed

10.48%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$10.93

Cash/ShareCash and equivalents per share

$2.85

FCF YieldFree cash flow as percentage of market cap

6.47%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$3.10

Dividend YieldAnnual dividend as percentage of stock price

1.83%

Financial Ratios Analysis data is not available for DGXFinancial Ratios Analysis details for DGX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for DGXSector Benchmarking details for DGX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Quest Diagnostics Incorporated Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Quest Diagnostics Incorporated. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Quest Diagnostics Incorporated's unique business strengths and challenges.

Key Financial Metrics for Quest Diagnostics Incorporated

For Quest Diagnostics Incorporated, essential financial indicators include EPS 8.35, PE 20.19, and ROE 0.14. These key ratios reveal insights into Quest Diagnostics Incorporated's profitability, valuation, and operational health. Understanding these metrics enables you to compare Quest Diagnostics Incorporated with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Quest Diagnostics Incorporated

Metrics like Net Margin 9.02% and ROA 5.94% shed light on how well Quest Diagnostics Incorporated is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Quest Diagnostics Incorporated can sustain its operations and continue growing in the future.

Valuation and Market Position of Quest Diagnostics Incorporated

Using ratios such as P/B Ratio 2.62 and PEG Ratio 3.47, investors can assess whether Quest Diagnostics Incorporated is appropriately valued based on its financials and growth potential. These figures, combined with Quest Diagnostics Incorporated's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Quest Diagnostics Incorporated

Financial health indicators, such as Debt/Equity Ratio 0.88 and Cash Flow $10.93, provide a snapshot of Quest Diagnostics Incorporated's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Quest Diagnostics Incorporated, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Quest Diagnostics Incorporated

Investing in Quest Diagnostics Incorporated based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Quest Diagnostics Incorporated focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;